Syndax Pharmaceuticals, Inc. (SNDX)
20.40
-0.22
(-1.04%)
USD |
NASDAQ |
Dec 11, 16:00
20.40
0.00 (0.00%)
After-Hours: 20:00
Syndax Pharmaceuticals Cash from Investing (Quarterly): 72.43M for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Arcutis Biotherapeutics, Inc. | -25.25M |
| ACADIA Pharmaceuticals, Inc. | -79.35M |
| Verastem, Inc. | -8.279M |
| Puma Biotechnology, Inc. | 0.506M |
| Krystal Biotech, Inc. | -4.286M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -70.54M |
| Cash from Financing (Quarterly) | 6.278M |
| Free Cash Flow | -311.01M |
| Free Cash Flow Per Share (Quarterly) | -0.8158 |
| Free Cash Flow to Equity (Quarterly) | -70.57M |
| Free Cash Flow to Firm (Quarterly) | -62.38M |
| Free Cash Flow Yield | -17.68% |